BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11987923)

  • 1. Monitoring disease in lymphoma and CLL patients using molecular techniques.
    Gribben JG
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):179-95. PubMed ID: 11987923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified sensitive method for the detection of B-cell clonality in lymphoid malignancies.
    Jilani I; Keating M; Day A; William W; Kantarjian H; O'brien S; Giles FJ; Albitar M
    Clin Lab Haematol; 2006 Oct; 28(5):325-31. PubMed ID: 16999724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of molecular diagnostics in low-grade lymphoma.
    Bahloul M; Asnafi V; Macintyre E
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):97-111. PubMed ID: 15694187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease assessment in chronic lymphocytic leukaemia.
    Sayala HA; Rawstron AC; Hillmen P
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):499-512. PubMed ID: 17707836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for stem cell transplantation in indolent lymphomas.
    Gribben JG
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S37-45. PubMed ID: 9672773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
    Bench AJ; Erber WN; Follows GA; Scott MA
    Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of oncogenes by chromosomal translocation in hematopoietic tumors].
    Okabe M; Miyagishima T
    Nihon Rinsho; 1992 Jun; 50(6):1341-6. PubMed ID: 1518155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of semi-quantitative monitoring of lymphomas using the comparative polymerase chain reaction].
    Slavícková A; Ivánek R; Cerný J; Sálková J; Trnĕný M
    Cas Lek Cesk; 2002 Nov; 141(23):735-8. PubMed ID: 12650030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular diagnosis of malignant B-cell lymphoma: detection of clonality and a brief review of problems with our results].
    Krsková L; Hilská I; Kopecká P; Soukup J; Kodet R
    Cas Lek Cesk; 2004; 143(3):191-4. PubMed ID: 15134040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of immunoglobulin gene rearrangement in B-cell malignancies.
    Ainoon O; Hamidah AB; Cheong SK; Hamidah HN
    Malays J Pathol; 2000 Jun; 22(1):5-11. PubMed ID: 16329531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma.
    Kang YH; Park CJ; Seo EJ; Huh J; Kim SB; Kang YK; Chi HS
    Cancer; 2002 Jun; 94(12):3073-82. PubMed ID: 12115337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
    Pfitzner T; Reiser M; Barth S; Borchmann P; Schulz H; Schinköthe T; Oberhäuser F; Wessels J; Tur M; Diehl V; Engert A
    Ann Hematol; 2002 May; 81(5):258-66. PubMed ID: 12029535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time quantitative PCR using hairpin-shaped clone-specific primers for minimal residual disease assessment in an animal model of human non-Hodgkin lymphoma.
    Gentilini F; Turba ME; Calzolari C; Cinotti S; Forni M; Zannoni A
    Mol Cell Probes; 2010 Feb; 24(1):6-14. PubMed ID: 19651205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is MRD eradication a desirable goal in CLL?
    Moreno C; Ritgen M; Rawstron A
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):97-107. PubMed ID: 20620974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of immunoglobulin chromosomal translocations by long-distance inverse polymerase chain reaction.
    Karran EL; Sonoki T; Dyer MJ
    Methods Mol Med; 2005; 115():217-30. PubMed ID: 15998970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.